❭ Research by medical division ❭ Surgery and Specialized Medicine ❭ Research Institute of Internal Medicine (RIIM) ❭
Page visits: 1
Scroll to top

Home Surgery and Specialized Medicine Research Institute of Internal Medicine (RIIM)

  • Immune regulation in atherosclerosis and other cardio metabolic diseases [Halvorsen]
  • Genomics and Metagenomics in Inflammatory Disorders [Hov]
  • Inflammatory Biomarkers in Cardiovascular and Metabolic Disease [Ueland]
  • The Experimental liver research group [Melum]
  • Infectious immunology [Trøseid]
  • Haemostasis, Thrombosis and Vascular Biology Research [Stavik]
  • RIIM Collaborators
  • RIIM publications
  • Research profile
  • Organization
  • Economy
  • Annual reports
  • Image gallery
  • Media outlets

Recent publications

Hanzely P, Holm K, Bjørnholt JV, Melum E, Hov JR, Rasmussen H (2025)
Efficacy of oral and rectal administration of human faecal microbiota transplant (FMT) in human microbiota-associated mouse models
Sci Rep (in press)
DOI 10.1038/s41598-025-32072-0, PubMed 41429881

Massonnaud CR, Peiffer-Smadja N, Poignard P, Jamard S, Goehringer F, Danion F, Reignier J, de Castro N, Garot D, Lapique EL, Lacombe K, Tolsma V, Faure E, Malvy D, Staub T, Courjon J, Cazenave-Roblot F, Dyrhol Riise AM, Leturnier P, Martin-Blondel G, Roger C, Akinosoglou K, Vincent Le Moing, Piroth L, Sellier P et al. (2025)
Efficacy, safety, pharmacokinetics, immunogenicity, and serum neutralizing activity of AZD7442 (tixagevimab-cilgavimab) in hospitalized COVID-19 patients: long-term results from the DisCoVeRy trial
Clin Microbiol Infect (in press)
DOI 10.1016/j.cmi.2025.12.014, PubMed 41429349

Befring AKC, Sandset PM (2025)
Uheldige konsekvenser av ny helseforskningslov
Tidsskr Nor Laegeforen, 145 (15)
DOI 10.4045/tidsskr.25.0653, PubMed 41410974

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)